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14S Abstracts June Supplement 2014D (P ¼ .01). The long-term primary patency rate after 24
months for the total population was 87.9% (88.0% for
TASC A, 88.5% for TASC B, 91.9% for TASC C, and
83.1% for TASC D, no statistically signiﬁcant difference
was shown when comparing these groups). The 24-
month primary patency rates were 92.1% for patients
treated with the self-expanding stent, 85.2% for patients
treated with the balloon-expandable stent, and 75.3%
for patients treated with a combination of both stents
(P ¼ .06). Univariate and multivariable regression ana-
lyses using Cox proportional hazards model identiﬁed
only kissing stent conﬁguration (P ¼ .0012) and obesity
(P ¼ .0109) as independent predictors of restenosis
(primary patency failure). Interestingly, because all
TASC groups enjoyed high levels of patency, neither
TASC category nor lesion length was predictive of
restenosis.
Conclusions: The 24-month data from this large, pro-
spective, multi-center study conﬁrm that endovascular
therapy may be considered the preferred ﬁrst-line treat-
ment option of aorto-iliac lesions, irrespectively of TASC
lesion category.
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Objectives: Open (OPAR) and endovascular (EPAR)
repair are both used to treat popliteal artery aneurysms
(PAA). We assessed outcomes of both modalities in the
treatment of asymptomatic PAA.
Methods: VQI databases (2010-2013) were queried
for patients undergoing asymptomatic PAA repair using
OPAR and EPAR. The groups were compared with
respect to demographics, medical history, and procedural
characteristics. Outcomes included major adverse limb
events (MALE), MALE and postoperative death
(MALE-POD), popliteal artery patency loss, and length
of stay (LOS). Proportional hazard Cox regression was
used to compare the outcomes across the treatment groups
and multivariate regression with backward elimination
procedure (a ¼ .5) was used to construct parsimonious
models.
Results: We identiﬁed 390 patients (221 OPAR, 169
EPAR). Preoperative comorbidities were similar between
the two groups, except for a higher rate of congestive
heart failure (11.8% vs 5.9%, P ¼ .043) and chronic
obstructive pulmonary disease (19.5% vs 11.8%, P ¼
.045) in the EPAR group. No in-hospital mortality was
observed. LOS was longer in the OPAR group(3.8 6 2.5 vs 1.4 6 1.9 days; P < .001). OPAR was asso-
ciated with lower hazard of MALE (0.35; 95% conﬁdence
interval [CI], 0.14-0.86), MALE-POD (0.28; 95% CI,
0.13-0.63), and popliteal artery patency loss (0.35; 95%
CI, 0.16-0.75). OPAR patients had a signiﬁcantly better
MALE-free survival (Fig).
Conclusions: This retrospective analysis suggests that
OPAR is associated with better outcomes than EPAR. Ul-
timately, the ongoing, adequately powered open vs endo-
vascular repair of PAA (OVERPAR) trial will deﬁnitively
compare these procedures.
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Author Disclosures: G. Doros: Nothing to disclose; M.
H. Eslami: Nothing to disclose; A. Farber: Nothing to
disclose; D. Rybin: Nothing to disclose.
VESS24.
Drug-Eluting Balloons (DEB) for Femoropopliteal
Lesions: Better Performance in De Novo Stenosis or
Occlusion Versus Restenosis
Monika Herten1, Stefan Stahlhoff2, Eva Schoenefeld1,
Giovanni Torsello1. 1Department of Vascular and
Endovascular Surgery, University-Hospital Muenster,
University of Muenster, Muenster, Germany;
2Department of Vascular Surgery, St. Franziskus-Hospital
Muenster, Muenster, Germany
Objectives: The use of drug-eluting balloons
(DEBs) in treating de novo arteriosclerotic lesions is
well established. However, the effectiveness of this tech-
nology in femoropopliteal restenosis has to be demon-
strated. The purpose of the study was to assess the
efﬁcacy of paclitaxel-DEB in restenotic (stented ¼ ISR
and nonstented) vs de novo stenotic femoropopliteal
arteries.
Methods: Patients undergoing femoropopliteal
endovascular intervention with DEB for restenosis (RE)
or de novo stenosis (DN) were prospectively enrolled.
Excluded were patients with additional atherectomy.
Clinical parameters (age, risk, risk factors) were compara-
ble within the groups apart from the treated lesion
lengths (RE, 130 6 65 mm; DN, 115 6 71 mm; P ¼
.041). Primary end point was the primary patency (PP)
rate at 12 months. Secondary end points were secondary
sustained clinical improvement measured by Rutherford
classiﬁcation and clinically driven target lesion revascular-
ization (TLR).
